Sitemap

February 17, 2006 Articles

Filter by Available Specialty
  1. FDA orders N.J. tissue recovery firm being monitored to close
  2. Gene therapy for AMD safe in phase 1 trial
  3. Iridex increases revenue by 13% in 2005
  4. Santen reports interim results with two new glaucoma drugs
  5. Some preservative-free eye drops at risk of contamination